pamidronate has been researched along with Cancer of Spleen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haidar, JH | 1 |
| Bazarbachi, A | 1 |
| Nasr, MR | 1 |
| El-Sabban, ME | 1 |
| Daher, R | 1 |
| Kage, K | 1 |
| Nagahama, T | 1 |
| Sekine, I | 1 |
| Maruyama, M | 1 |
| Ogata, E | 1 |
2 other studies available for pamidronate and Cancer of Spleen
| Article | Year |
|---|---|
Signet ring-like light chain myeloma with systemic spread.
Topics: Anemia; Antineoplastic Agents; Bone Marrow Examination; Combined Modality Therapy; Diagnostic Errors | 2003 |
A remarkable improvement of clinical manifestations in a breast cancer patient with widespread bone metastases after administration of pamidronate.
Topics: Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Carcinoma, Lobular; Diphosphonates; Female; | 1997 |